• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

纤溶参数与早期动脉粥样硬化的关联。社区动脉粥样硬化风险研究(ARIC研究)。

Association of fibrinolytic parameters with early atherosclerosis. The ARIC Study. Atherosclerosis Risk in Communities Study.

作者信息

Salomaa V, Stinson V, Kark J D, Folsom A R, Davis C E, Wu K K

机构信息

Department of Epidemiology and Health Promotion, National Public Health Institute, Helsinki, Finland.

出版信息

Circulation. 1995 Jan 15;91(2):284-90. doi: 10.1161/01.cir.91.2.284.

DOI:10.1161/01.cir.91.2.284
PMID:7805229
Abstract

BACKGROUND

Thrombosis, provoked by a rupture of an atherosclerotic plaque, plays a crucial role in precipitating a coronary heart disease event. Its role at the early stage of atherosclerosis has, however, been unclear, but it has been hypothesized that thrombosis or defective fibrinolysis contributes to the progression of atherosclerotic lesions.

METHODS AND RESULTS

We studied the association of plasminogen activator inhibitor antigen (PAI-1), tissue-type plasminogen activator antigen (TPA), and D-dimer with early atherosclerosis in a cross-sectional case-control study involving 457 pairs chosen from the biracial cohort of the Atherosclerosis Risk in Communities (ARIC) Study. As examined by B-mode ultrasound, patients (cases) had intima-media thickness of carotid arteries above the 90th percentile and control subjects had thickness below the 75th percentile of the ARIC cohort. Persons with a history of heart disease, stroke, or claudication were excluded from the case-control selection. PAI-1, TPA, and D-dimer were higher in patients than in control subjects (P < or = .001, Wilcoxon signed rank statistic). In conditional logistic regression analyses, the odds ratios of carotid atherosclerosis were, for PAI-1, for example, 1.22, 1.54, and 1.60 in the second, third, and fourth quartiles compared with the first quartile (P < .0001, test of linear trend, adjusting for age, systolic blood pressure, total cholesterol, acetylsalicylic acid use, and time of blood draw). Corresponding tests for D-dimer and TPA also showed an increasing trend (P < .0001).

CONCLUSIONS

The findings support the hypothesis that thrombosis and fibrinolysis play a role at the early stage of the atherosclerotic process.

摘要

背景

动脉粥样硬化斑块破裂引发的血栓形成在冠心病事件的发生中起关键作用。然而,其在动脉粥样硬化早期阶段的作用尚不清楚,但有假说认为血栓形成或纤维蛋白溶解功能缺陷会促使动脉粥样硬化病变进展。

方法与结果

我们在一项横断面病例对照研究中,对从社区动脉粥样硬化风险(ARIC)研究的双种族队列中选取的457对研究对象进行了研究,以探讨纤溶酶原激活物抑制剂抗原(PAI-1)、组织型纤溶酶原激活物抗原(TPA)和D-二聚体与早期动脉粥样硬化的关联。通过B型超声检查,患者(病例组)颈动脉内膜中层厚度高于ARIC队列的第90百分位数,而对照者的厚度低于第75百分位数。病例对照选择中排除了有心脏病、中风或间歇性跛行病史的人。患者的PAI-1、TPA和D-二聚体水平高于对照者(P≤0.001,Wilcoxon符号秩统计量)。在条件逻辑回归分析中,例如,与第一四分位数相比,PAI-1在第二、第三和第四四分位数时颈动脉粥样硬化的比值比分别为1.22、1.54和1.60(P<0.0001,线性趋势检验,校正年龄、收缩压、总胆固醇、阿司匹林使用情况和采血时间)。D-二聚体和TPA的相应检验也显示出增加趋势(P<0.0001)。

结论

这些发现支持了血栓形成和纤维蛋白溶解在动脉粥样硬化进程早期起作用的假说。

相似文献

1
Association of fibrinolytic parameters with early atherosclerosis. The ARIC Study. Atherosclerosis Risk in Communities Study.纤溶参数与早期动脉粥样硬化的关联。社区动脉粥样硬化风险研究(ARIC研究)。
Circulation. 1995 Jan 15;91(2):284-90. doi: 10.1161/01.cir.91.2.284.
2
Relation of hormone-replacement therapy to measures of plasma fibrinolytic activity. Atherosclerosis Risk in Communities (ARIC) Study Investigators.激素替代疗法与血浆纤维蛋白溶解活性指标的关系。社区动脉粥样硬化风险(ARIC)研究调查人员。
Circulation. 1996 Jun 1;93(11):1970-5. doi: 10.1161/01.cir.93.11.1970.
3
Fibrinolytic activity in peripheral atherosclerosis in the elderly.老年人外周动脉粥样硬化中的纤溶活性。
Thromb Haemost. 1999 Feb;81(2):275-80.
4
Prospective study of fibrinolytic factors and incident coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study.纤溶因子与冠心病发病的前瞻性研究:社区动脉粥样硬化风险(ARIC)研究
Arterioscler Thromb Vasc Biol. 2001 Apr;21(4):611-7. doi: 10.1161/01.atv.21.4.611.
5
Fibrinogen and fibrinolytic activity in CAPD patients with atherosclerosis and its correlation with serum albumin.伴有动脉粥样硬化的持续性非卧床腹膜透析患者的纤维蛋白原和纤溶活性及其与血清白蛋白的相关性
Perit Dial Int. 1997 Mar-Apr;17(2):157-61.
6
Progressive intermittent claudication is associated with impaired fibrinolysis.进行性间歇性跛行与纤维蛋白溶解功能受损有关。
J Vasc Surg. 1998 Apr;27(4):645-50. doi: 10.1016/s0741-5214(98)70229-0.
7
Inhibitors of fibrinolysis are elevated in atherosclerotic plaque.纤溶抑制剂在动脉粥样硬化斑块中升高。
Arterioscler Thromb Vasc Biol. 1996 Apr;16(4):539-45. doi: 10.1161/01.atv.16.4.539.
8
Role of fibrinolytic parameters and plasminogen activator inhibitor 1 (PAI-1) promoter polymorphism on premature atherosclerosis in SLE patients.纤维蛋白溶解参数和纤溶酶原激活物抑制剂 1(PAI-1)启动子多态性在系统性红斑狼疮患者早发动脉粥样硬化中的作用。
Lupus. 2011 Oct;20(10):1063-71. doi: 10.1177/0961203311404911. Epub 2011 Jun 30.
9
Tissue plasminogen activator antigen and D-dimer as markers for atherothrombotic risk among healthy postmenopausal women.组织型纤溶酶原激活物抗原和D - 二聚体作为健康绝经后女性动脉粥样硬化血栓形成风险的标志物。
Circulation. 2004 Jul 20;110(3):292-300. doi: 10.1161/01.CIR.0000134965.73212.A6. Epub 2004 Jul 6.
10
Increased fibrinolytic activity during use of oral contraceptives is counteracted by an enhanced factor XI-independent down regulation of fibrinolysis: a randomized cross-over study of two low-dose oral contraceptives.口服避孕药使用期间纤溶活性增加被纤溶增强的不依赖于因子XI的下调所抵消:两种低剂量口服避孕药的随机交叉研究。
Thromb Haemost. 2000 Jul;84(1):9-14.

引用本文的文献

1
Vascular Assessment in Adult Survivors of Childhood Cancer: A St. Jude Lifetime Cohort Study Report.儿童癌症成年幸存者的血管评估:圣犹大终身队列研究报告
JACC Adv. 2025 Jun;4(6 Pt 1):101820. doi: 10.1016/j.jacadv.2025.101820. Epub 2025 May 29.
2
Predictors of functional and morphological arterial wall properties in coronary artery disease patients with increased lipoprotein (a) levels before and after treatment with proprotein convertase subtilisin-kexin type 9 inhibitors.载脂蛋白(a)水平升高的冠心病患者经前蛋白转化酶枯草溶菌素 9 抑制剂治疗前后动脉壁功能和形态学特性的预测因素。
Cardiovasc Ultrasound. 2023 Aug 14;21(1):15. doi: 10.1186/s12947-023-00313-9.
3
Cardiovascular Disease in Testicular Cancer Survivors: Identification of Risk Factors and Impact on Quality of Life.
睾丸癌幸存者的心血管疾病:危险因素的识别及其对生活质量的影响。
J Clin Oncol. 2023 Jul 1;41(19):3512-3522. doi: 10.1200/JCO.22.01016. Epub 2023 Apr 18.
4
Investigating the two regimes of fibrin clot lysis: an experimental and computational approach.研究纤维蛋白凝块溶解的两种状态:一种实验和计算方法。
Biophys J. 2021 Sep 21;120(18):4091-4106. doi: 10.1016/j.bpj.2021.08.005. Epub 2021 Aug 10.
5
NF-κB and tPA Signaling in Kidney and Other Diseases.NF-κB 和 tPA 在肾脏和其他疾病中的信号转导作用。
Cells. 2020 May 29;9(6):1348. doi: 10.3390/cells9061348.
6
Carotid plaque composition by CT angiography in asymptomatic subjects: a head-to-head comparison to ultrasound.CT 血管造影在无症状患者中颈动脉斑块成分分析:与超声的头对头比较。
Eur Radiol. 2019 Nov;29(11):5920-5931. doi: 10.1007/s00330-019-06086-y. Epub 2019 Mar 26.
7
The Influence of Tissue Plasminogen Activator I/D Polymorphism on the tPA Response to Exercise.组织型纤溶酶原激活剂I/D多态性对运动时组织型纤溶酶原激活剂反应的影响。
Int J Exerc Sci. 2018 Oct 1;11(3):1136-1144. doi: 10.70252/HFSZ9901. eCollection 2018.
8
Causal Effect of Plasminogen Activator Inhibitor Type 1 on Coronary Heart Disease.1型纤溶酶原激活物抑制剂对冠心病的因果效应
J Am Heart Assoc. 2017 May 26;6(6):e004918. doi: 10.1161/JAHA.116.004918.
9
The effect of acute aerobic exercise on hemostasis in obstructive sleep apnea.急性有氧运动对阻塞性睡眠呼吸暂停患者止血功能的影响。
Sleep Breath. 2017 Sep;21(3):623-629. doi: 10.1007/s11325-017-1477-6. Epub 2017 Feb 14.
10
The effects of residual platelets in plasma on plasminogen activator inhibitor-1 and plasminogen activator inhibitor-1-related assays.血浆中残留血小板对纤溶酶原激活物抑制剂-1及纤溶酶原激活物抑制剂-1相关检测的影响。
PLoS One. 2017 Feb 3;12(2):e0171271. doi: 10.1371/journal.pone.0171271. eCollection 2017.